GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) » Definitions » Short-Term Debt

Changzhou Qianhong Biopharma Co (SZSE:002550) Short-Term Debt : ¥56 Mil (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Changzhou Qianhong Biopharma Co Short-Term Debt?

Changzhou Qianhong Biopharma Co's Short-Term Debt for the quarter that ended in Mar. 2024 was ¥56 Mil.

Changzhou Qianhong Biopharma Co's quarterly Short-Term Debt increased from Sep. 2023 (¥20 Mil) to Dec. 2023 (¥56 Mil) and increased from Dec. 2023 (¥56 Mil) to Mar. 2024 (¥56 Mil).

Changzhou Qianhong Biopharma Co's annual Short-Term Debt increased from Dec. 2021 (¥89 Mil) to Dec. 2022 (¥100 Mil) but then declined from Dec. 2022 (¥100 Mil) to Dec. 2023 (¥56 Mil).

Changzhou Qianhong Biopharma Co Short-Term Debt Historical Data

The historical data trend for Changzhou Qianhong Biopharma Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changzhou Qianhong Biopharma Co Short-Term Debt Chart

Changzhou Qianhong Biopharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 344.24 41.85 89.46 100.10 55.62

Changzhou Qianhong Biopharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 300.83 300.55 20.02 55.62 56.21

Changzhou Qianhong Biopharma Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Changzhou Qianhong Biopharma Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Changzhou Qianhong Biopharma Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Changzhou Qianhong Biopharma Co (SZSE:002550) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) » Definitions » Short-Term Debt
Comparable Companies
SHSE:600351 SZSE:002907 SZSE:301509 SZSE:301211 SZSE:300267 SZSE:301089 SZSE:300158 SZSE:300683 SZSE:300039 SZSE:002349 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Number 90 Changjiang Middle Road, Xinbei distract, Jiangsu Province, Changzhou, CHN, 213022
Website
http://www.qhsh.com.cn
Changzhou Qianhong Biopharma Co Ltd engages in the research and development, production, and sale of biopharmaceutical products with the focus on polysaccharides and enzymes in China. The company provides various products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; and kallidinogenase kallikrein and heparinoid.

Changzhou Qianhong Biopharma Co (SZSE:002550) Headlines

No Headlines